The global immunoassay market size accounted for USD 35.57 billion in 2024, grew to USD 37.23 billion in 2025 and is predicted to surpass around USD 56.2 billion by 2034, representing a healthy CAGR of 4.68% between 2024 and 2034. The North America immunoassay market size is calculated at USD 12.81 billion in 2024 and is expected to grow at a fastest CAGR of 4.81% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Immunoassay Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Immunoassay Market, by Product, 2024-2034
8.1.1. Reagents & Kits
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Analyzer
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Software and Services
8.1.3.1. Market Revenue and Forecast (2021-2034)
9.1. Immunoassay Market, by Technology, 2024-2034
9.1.1. ELISA
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Rapid Tests
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. ELISpot
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Western Blotting
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Radioimmunoassay
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.6. Other technologies
9.1.5.1. Market Revenue and Forecast (2021-2034)
10.1. Immunoassay Market, by Specimen, 2024-2034
10.1.1. Blood
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Saliva
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Urine
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Other Specimen
10.1.4.1. Market Revenue and Forecast (2021-2034)
11.1. Immunoassay Market, by Application, 2024-2034
11.1.1. Infectious diseases
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Endocrinology
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Oncology
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Bone and mineral disorders
11.1.4.1. Market Revenue and Forecast (2021-2034)
11.1.5. Cardiology
11.1.5.1. Market Revenue and Forecast (2021-2034)
11.1.6. Blood screening
11.1.6.1. Market Revenue and Forecast (2021-2034)
11.1.7. Autoimmune Disorders
11.1.7.1. Market Revenue and Forecast (2021-2034)
11.1.8. Allergy Diagnostics
11.1.8.1. Market Revenue and Forecast (2021-2034)
11.1.9. Toxicology
11.1.9.1. Market Revenue and Forecast (2021-2034)
11.1.10. Newborn Screening
11.1.10.1. Market Revenue and Forecast (2021-2034)
11.1.11. Other Application
11.1.11.1. Market Revenue and Forecast (2021-2034)
12.1. Immunoassay Market, by End-User, 2024-2034
12.1.1. Hospitals & Clinics
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Clinical Laboratories
12.1.2.1. Market Revenue and Forecast (2021-2034)
12.1.3. Pharmaceutical & Biotechnology Companies And Cro
12.1.3.1. Market Revenue and Forecast (2021-2034)
12.1.4. Blood Banks
12.1.4.1. Market Revenue and Forecast (2021-2034)
12.1.5. Research & Academic Laboratories
12.1.5.1. Market Revenue and Forecast (2021-2034)
12.1.6. Home Care Setting
12.1.6.1. Market Revenue and Forecast (2021-2034)
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2021-2034)
13.1.2. Market Revenue and Forecast, by Technology (2021-2034)
13.1.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.1.4. Market Revenue and Forecast, by Application (2021-2034)
13.1.5. Market Revenue and Forecast, by End-User (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.1.6.2. Market Revenue and Forecast, by Technology (2021-2034)
13.1.6.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.1.6.4. Market Revenue and Forecast, by Application (2021-2034)
13.1.6.5. Market Revenue and Forecast, by End-User (2021-2034)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product (2021-2034)
13.1.7.2. Market Revenue and Forecast, by Technology (2021-2034)
13.1.7.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.1.7.4. Market Revenue and Forecast, by Application (2021-2034)
13.1.7.5. Market Revenue and Forecast, by End-User (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.2. Market Revenue and Forecast, by Technology (2021-2034)
13.2.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.2.4. Market Revenue and Forecast, by Application (2021-2034)
13.2.5. Market Revenue and Forecast, by End-User (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.6.2. Market Revenue and Forecast, by Technology (2021-2034)
13.2.6.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.2.7. Market Revenue and Forecast, by Application (2021-2034)
13.2.8. Market Revenue and Forecast, by End-User (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.9.2. Market Revenue and Forecast, by Technology (2021-2034)
13.2.9.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.2.10. Market Revenue and Forecast, by Application (2021-2034)
13.2.11. Market Revenue and Forecast, by End-User (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.12.2. Market Revenue and Forecast, by Technology (2021-2034)
13.2.12.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.2.12.4. Market Revenue and Forecast, by Application (2021-2034)
13.2.13. Market Revenue and Forecast, by End-User (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.14.2. Market Revenue and Forecast, by Technology (2021-2034)
13.2.14.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.2.14.4. Market Revenue and Forecast, by Application (2021-2034)
13.2.15. Market Revenue and Forecast, by End-User (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.2. Market Revenue and Forecast, by Technology (2021-2034)
13.3.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.3.4. Market Revenue and Forecast, by Application (2021-2034)
13.3.5. Market Revenue and Forecast, by End-User (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.6.2. Market Revenue and Forecast, by Technology (2021-2034)
13.3.6.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.3.6.4. Market Revenue and Forecast, by Application (2021-2034)
13.3.7. Market Revenue and Forecast, by End-User (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.8.2. Market Revenue and Forecast, by Technology (2021-2034)
13.3.8.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.3.8.4. Market Revenue and Forecast, by Application (2021-2034)
13.3.9. Market Revenue and Forecast, by End-User (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.10.2. Market Revenue and Forecast, by Technology (2021-2034)
13.3.10.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.3.10.4. Market Revenue and Forecast, by Application (2021-2034)
13.3.10.5. Market Revenue and Forecast, by End-User (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.11.2. Market Revenue and Forecast, by Technology (2021-2034)
13.3.11.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.3.11.4. Market Revenue and Forecast, by Application (2021-2034)
13.3.11.5. Market Revenue and Forecast, by End-User (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.2. Market Revenue and Forecast, by Technology (2021-2034)
13.4.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.4.4. Market Revenue and Forecast, by Application (2021-2034)
13.4.5. Market Revenue and Forecast, by End-User (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.6.2. Market Revenue and Forecast, by Technology (2021-2034)
13.4.6.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.4.6.4. Market Revenue and Forecast, by Application (2021-2034)
13.4.7. Market Revenue and Forecast, by End-User (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.8.2. Market Revenue and Forecast, by Technology (2021-2034)
13.4.8.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.4.8.4. Market Revenue and Forecast, by Application (2021-2034)
13.4.9. Market Revenue and Forecast, by End-User (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.10.2. Market Revenue and Forecast, by Technology (2021-2034)
13.4.10.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.4.10.4. Market Revenue and Forecast, by Application (2021-2034)
13.4.10.5. Market Revenue and Forecast, by End-User (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.11.2. Market Revenue and Forecast, by Technology (2021-2034)
13.4.11.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.4.11.4. Market Revenue and Forecast, by Application (2021-2034)
13.4.11.5. Market Revenue and Forecast, by End-User (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2021-2034)
13.5.2. Market Revenue and Forecast, by Technology (2021-2034)
13.5.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.5.4. Market Revenue and Forecast, by Application (2021-2034)
13.5.5. Market Revenue and Forecast, by End-User (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.5.6.2. Market Revenue and Forecast, by Technology (2021-2034)
13.5.6.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.5.6.4. Market Revenue and Forecast, by Application (2021-2034)
13.5.7. Market Revenue and Forecast, by End-User (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2021-2034)
13.5.8.2. Market Revenue and Forecast, by Technology (2021-2034)
13.5.8.3. Market Revenue and Forecast, by Specimen (2021-2034)
13.5.8.4. Market Revenue and Forecast, by Application (2021-2034)
13.5.8.5. Market Revenue and Forecast, by End-User (2021-2034)
14.1. Abbott Laboratories
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Danaher Corporation (Beckman Coulter)
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Quidel Corporation
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Ortho Clinical Diagnostics
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Sysmex Corporation
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Bio-Rad Laboratories, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Becton, Dickinson, and Company
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. F. Hoffmann-La Roche AG
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Thermo Fisher Scientific, Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Siemens Healthinners
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample